Article
07 Jul 2026
Borders Not An Escape: How Foreign Companies Face Canadian Patent Liability
AUTHORS CONTENT
Article
29 Jan 2026
Life Sciences In Canada: Year In Review 2025
Article
23 Jan 2026
Patent Infringement By Common Design Makes Its Entrance In Canada
Article
25 Jan 2024
2023 Year In Review: Life Sciences In Canada
Article
08 Aug 2023
Federal Court Affirms OSIP Decision To Not List STELARA® On Patent Register
Article
01 May 2023
Ontario Superior Court Dismisses Claim For Section 8 Damages
Article
22 Nov 2022
Supreme Court Of Canada Upholds $644-Million Award For Patent Infringement; Provides Fresh Guidance For Conducting An Accounting Of Profits
Article
30 Jun 2022
A Small-Screen Patent Infringement Case With A Large Royalty Payment On The Line
Article
25 Apr 2022
Update On The Amendments To The Patented Medicines Regulations – Government Will Not Proceed With Certain Amendments
Article
24 Feb 2022
Two Major Amendments To The Patented Medicines Regulations Declared Ultra Vires And Unconstitutional
Article
17 Aug 2021
Federal Court Of Appeal Upholds CCM's Defence Of Bauer's Patent Infringement Lawsuit
Article
29 Jul 2021
FCA Upholds Award Of Compound Interest In Cefaclor Damages Appeal
Article
16 Mar 2021
Show Me The Money: The Evolving Approach To Costs In The Federal Court
Article
15 Mar 2021
Takeda Successfully Defends Canadian VYVANSE® Patent On Appeal
Article
22 Feb 2021
Patented Medicines Regulations - No Implied Limitation Period In Section 8.2
Article
22 Feb 2021
Patented Medicines Regulations - No Implied Limitation Period In Section 8.2
Article
10 Jun 2020
Infringement Action Under PM(NOC) Regulations Cannot Become Moot
Article
01 Jul 2016
Janssen Awarded Damages Almost 10 Years After Teva Found To Have Infringed Levaquin® Patent
